Drug Type Small molecule drug |
Synonyms 1,3-Benzenediol, 1,3-Dihydroxybenzene, Resorcin (JAN) + [4] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC6H6O2 |
InChIKeyGHMLBKRAJCXXBS-UHFFFAOYSA-N |
CAS Registry108-46-3 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Alopecia Areata | China | - | - |
Dermatitis, Seborrheic | China | - | - |
EADV2022 Manual | Phase 1 | 60 | 10% resorcinol | (ibzplmjwyc) = Treatment with resorcinol 10% resulted in asignificant reduction in mean total lesion countat 4, 12 and 24 weeks of resorcinol application. lorcemscyf (ntzjdihkcx ) View more | Positive | 07 Sep 2022 | |
clindamycin lotion 1% |